We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byKevin Fields
Modified over 5 years ago
Outcomes for Lung Transplantation for Lung Cancer in the United Network for Organ Sharing Registry Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S. Bryant, MSPH, MD, Anthony W. Kim, MD, MS, Jasleen Kukreja, MD, MPH, David P. Mason, MD, Christian A. Bermudez, MD, Frank C. Detterbeck, MD, Daniel J. Boffa, MD The Annals of Thoracic Surgery Volume 94, Issue 3, Pages (September 2012) DOI: /j.athoracsur Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Overall survival is shown for the bronchoalveolar carcinoma (BAC)/cancer cohort (dashed line; n = 29) compared with the general lung transplantation cohort (solid line; n = 21,524). (HR = hazard ratio.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Overall survival is shown for bronchoalveolar carcinoma/cancer patients with invasive (dashed line; n = 13) or noninvasive (solid line; n = 14) tumors. (HR = hazard ratio.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Overall survival is shown for bronchoalveolar carcinoma/cancer patients in the presence (dashed line; n = 7), or absence (solid line; n = 20) of lymph node (LN) metastases. (HR = hazard ratio.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Photodynamic Laser Therapy for Lesions in the Airway
What Predicts Long-Term Survival After Heart Transplantation
Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,
Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C
Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database
Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database Daniel J. Boffa,
Joshua E. Rosen, BASc, Hari B
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
© 2023 SlidePlayer.com Inc. All rights reserved.